Artelo Biosciences, Inc. (ARTL)
NASDAQ: ARTL · Real-Time Price · USD
2.330
+0.130 (5.91%)
Oct 28, 2026, 2:26 PM EDT - Market open
Artelo Biosciences Market Cap
Artelo Biosciences has a market cap or net worth of $1.28 million as of October 28, 2026. It is the 49,110th most valuable company in the world and the 6,659th biggest in the United States. Its market cap has decreased by 71.64% in one year.
Market Cap
1.28M
Enterprise Value
-2.87M
1-Year Change
-71.64%
Global Rank
Country Rank
#6,659 United States
Category
ChartMarket Cap Chart
Since June 21, 2019, Artelo Biosciences's market cap has decreased from $12.30M to $1.28M, a decrease of -89.62%. That is a compound annual growth rate of -26.51%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 27, 2026 | 1.10M | -56.00% |
| Dec 31, 2025 | 2.50M | -26.47% |
| Dec 31, 2024 | 3.40M | -24.44% |
| Dec 29, 2023 | 4.50M | -45.78% |
| Dec 30, 2022 | 8.30M | -62.27% |
| Dec 31, 2021 | 22.00M | 100.00% |
| Dec 31, 2020 | 11.00M | 18.28% |
| Dec 31, 2019 | 9.30M | -24.39% |
| Jun 21, 2019 | 12.30M | - |
View and export this data all the way back to 2019. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| GeoVax Labs | 1.87M |
| Propanc Biopharma | 1.77M |
| XORTX Therapeutics | 1.67M |
| Matinas BioPharma Holdings | 1.67M |
| Onconetix | 1.65M |
| Curis | 1.59M |
| Genprex | 1.48M |
| Lunai Bioworks | 1.48M |